Finance

Lists
Why is CAMP down 7.68%?
Dive Deeper
CAMP:NASDAQ
CAMP4 Therapeutics Corp
US$4.33
-7.68%
(-0.36) 1D
US$4.33
0.00% (0.00)
After hours
Closed: ኖቬም 10, 4:00:01 ከሰዓት ጂ ኤም ቲ-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CAMP...
Open
US$4.63
High
US$4.63
Low
US$4.25
Mkt. cap
271.73 ሚ
Avg. vol.
228.07 ሺ
Volume
0.00
52-wk high
US$7.75
52-wk low
US$2.90
EPS
-US$2.01
Shares outstanding
62.75 ሚ
No. of employees
48
Open
US$4.63
High
US$4.63
Low
US$4.25
Mkt. cap
271.73 ሚ
Avg. vol.
228.07 ሺ
Volume
0.00
52-wk high
US$7.75
52-wk low
US$2.90
EPS
-US$2.01
Shares outstanding
62.75 ሚ
No. of employees
48
News stories
From web sources and news partners
About CAMP4 Therapeutics Corp
CEO-
Employees48
Founded2015
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websitecamp4tx.com
Analyst ratings
Based on 7 analysts giving stock ratings to CAMP in the past 3 months
Strong buy
Buy
7
Hold
0
Sell
0
12-month forecast
Based on 7 Wall Street analysts offering 12 month price targets for CAMP in the last 3 months.
Highest
Current US$4.33
US$15.00 (+246.42%)
Average
US$9.00 (+107.85%)
Lowest
US$6.00 (+38.57%)
Analyst
Recommendation
Action
Price target
Projected
Date
Yun Zhong
Wedbush
Buy
Maintained
US$8.00
+84.8%
11/06/2026
Steven Seedhouse
Cantor Fitzgerald
Buy
Maintained
US$7.00
+61.7%
11/05/2026
Edward Tenthoff
Piper Sandler
Buy
Reiterated
US$15.00
+246.4%
11/06/2026
Tiago Fauth
Raymond James
Buy
Initiated
US$10.00
+130.9%
10/23/2026
Joseph Stringer
Needham
Buy
Initiated
US$8.00
+84.8%
10/15/2026
Keay Nakae
Chardan Capital
Buy
Reiterated
US$6.00
+38.6%
09/29/2026
Myles Minter
William Blair
Buy
Reiterated
-
-
09/29/2026
Anupam Rama
J.P. Morgan
Buy
Upgraded
US$9.00
+107.9%
06/22/2026
Seema Sheoran
Rodman & Renshaw
Buy
Initiated
US$7.00
+61.7%
04/14/2026
Mani Foroohar
Leerink Partners
Buy
Maintained
US$9.00
+107.9%
04/02/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
ዲሴም 2025
ማርች 2026
ጁን 2026
ሴፕቴ 2026
Revenue
348.00 ሺ
1.29 ሚ
1.78 ሚ
1.90 ሚ
Cost of goods sold
8.36 ሚ
10.16 ሚ
10.82 ሚ
11.43 ሚ
Cost of revenue
8.36 ሚ
10.16 ሚ
10.82 ሚ
11.43 ሚ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.77 ሚ
4.20 ሚ
4.34 ሚ
4.49 ሚ
Operating expense
4.77 ሚ
4.20 ሚ
4.34 ሚ
4.49 ሚ
Total operating expenses
13.12 ሚ
14.36 ሚ
15.16 ሚ
15.93 ሚ
Operating income
-12.78 ሚ
-13.07 ሚ
-13.38 ሚ
-14.03 ሚ
Other non operating income
-28.22 ሚ
-6.17 ሚ
-20.96 ሚ
-15.91 ሚ
EBT including unusual items
-40.28 ሚ
-18.33 ሚ
-33.53 ሚ
-28.96 ሚ
EBT excluding unusual items
-40.28 ሚ
-18.33 ሚ
-33.53 ሚ
-28.96 ሚ
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-40.28 ሚ
-18.33 ሚ
-33.53 ሚ
-28.96 ሚ
Net profit margin
-11,575.86%
-1,416.62%
-1,884.77%
-1,524.80%
Earnings per share
-0.23
-0.21
-0.22
-0.17
Interest and investment income
716.00 ሺ
910.00 ሺ
807.00 ሺ
984.00 ሺ
Interest expense
-
-
-
-
Net interest expenses
716.00 ሺ
910.00 ሺ
807.00 ሺ
984.00 ሺ
Depreciation and amortization charges
-
-
-
-
EBITDA
-12.40 ሚ
-12.55 ሚ
-12.86 ሚ
-13.51 ሚ
Gain or loss from assets sale
191.00 ሺ
-
-
98.00 ሺ
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google መተግበሪያዎች